Impact of CY 2026 OPPS/ASC Final Rule Policies We are finalizing: (1) removal of the HCHE measure beginning with the CY 2025 reporting period/CY 2027 program determination
Patients should maintain a symptom diary documenting the timing, severity, and duration of side effects, along with dietary intake and other relevant factors
Ultimately, maximizing long-term results requires viewing tirzepatide as one component of comprehensive obesity management, integrated with lifestyle medicine, behavioral support, and ongoing clinical monitoring to achieve sustained metabolic health improvements
The patient should maintain that dose for about a month before an attempt is made to increase the dose again
Powder Due to its versatility, moringa leaf powder is a popular option
Omadas virtual-first model combines human-led care teams, connected devices, and AI-enabled technology to deliver personalized care at scale, including support for GLP-1 therapy